Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03233152
Title Intra-tumoral Ipilimumab Plus Intravenous Nivolumab Following the Resection of Recurrent Glioblastoma (GlitIpNi)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Universitair Ziekenhuis Brussel
Indications

glioblastoma

Therapies

Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries BEL


No variant requirements are available.